​

Funding Round

Series B - Beta Bionics

Series B - Beta Bionics

Investment Firm

Overview

Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet.

Announced Date

Jan 08, 2019

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

4

Investor Name
Participant InvestorRTW Investments
Participant InvestorArrowMark Partners
Participant InvestorZealand Pharma
Participant InvestorDexcom

Round Details and Background

Beta Bionics raised $63000000 on 2019-01-08 in Series B

Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 02, 2018
Grant - Beta Bionics
1-2.0M
Dec 27, 2017
Venture Round - Beta Bionics
-2.5M
Feb 17, 2022
Series C - Beta Bionics
9-57.0M
Aug 30, 2023
Series D - Beta Bionics
11-100.0M

Recent Activity

There is no recent news or activity for this profile.